These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 22476196)

  • 1. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
    Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
    Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.
    Lourenco MV; Clarke JR; Frozza RL; Bomfim TR; Forny-Germano L; Batista AF; Sathler LB; Brito-Moreira J; Amaral OB; Silva CA; Freitas-Correa L; Espírito-Santo S; Campello-Costa P; Houzel JC; Klein WL; Holscher C; Carvalheira JB; Silva AM; Velloso LA; Munoz DP; Ferreira ST; De Felice FG
    Cell Metab; 2013 Dec; 18(6):831-43. PubMed ID: 24315369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer’s disease: the new promise.
    Strittmatter WJ
    J Clin Invest; 2012 Apr; 122(4):1191. PubMed ID: 22754953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.
    Solmaz V; Çınar BP; Yiğittürk G; Çavuşoğlu T; Taşkıran D; Erbaş O
    Eur J Pharmacol; 2015 Oct; 765():482-7. PubMed ID: 26386291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's disease.
    Long-Smith CM; Manning S; McClean PL; Coakley MF; O'Halloran DJ; Holscher C; O'Neill C
    Neuromolecular Med; 2013 Mar; 15(1):102-14. PubMed ID: 23011726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons.
    Takach O; Gill TB; Silverman MA
    Neurobiol Aging; 2015 Mar; 36(3):1378-82. PubMed ID: 25543463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
    J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease.
    Rahman SO; Kaundal M; Salman M; Shrivastava A; Parvez S; Panda BP; Akhter M; Akhtar M; Najmi AK
    Eur J Pharmacol; 2020 Dec; 889():173522. PubMed ID: 32866503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.
    Higaki S; Muramatsu M; Matsuda A; Matsumoto K; Satoh JI; Michikawa M; Niida S
    PLoS One; 2018; 13(5):e0196929. PubMed ID: 29738527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model.
    Han X; Ma Y; Liu X; Wang L; Qi S; Zhang Q; Du Y
    J Neural Transm (Vienna); 2012 Nov; 119(11):1407-16. PubMed ID: 22527777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahippocampal administration of amyloid-β(1-42) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism.
    Pearson-Leary J; McNay EC
    J Alzheimers Dis; 2012; 30(2):413-22. PubMed ID: 22430529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.
    Han K; Jia N; Zhong Y; Shang X
    J Cell Biochem; 2018 Apr; 119(4):3111-3117. PubMed ID: 29058763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine Phosphorylation of IRS1 Correlates with Aβ-Unrelated Memory Deficits and Elevation in Aβ Level Prior to the Onset of Memory Decline in AD.
    Wang W; Tanokashira D; Fukui Y; Maruyama M; Kuroiwa C; Saito T; Saido TC; Taguchi A
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
    Nakamura N; Ohyagi Y; Imamura T; Yanagihara YT; Iinuma KM; Soejima N; Murai H; Yamasaki R; Kira JI
    J Alzheimers Dis; 2017; 58(4):1151-1161. PubMed ID: 28550243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.
    Chen S; Liu AR; An FM; Yao WB; Gao XD
    Age (Dordr); 2012 Oct; 34(5):1211-24. PubMed ID: 21901364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
    Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
    Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.